{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:15:15Z","timestamp":1792109715015,"version":"4.4.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,11,23]],"date-time":"2022-11-23T00:00:00Z","timestamp":1669161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,11,23]],"date-time":"2022-11-23T00:00:00Z","timestamp":1669161600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Bone Miner Metab"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1007\/s00774-022-01382-y","type":"journal-article","created":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T08:53:18Z","timestamp":1669279998000},"page":"327-336","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["Management of cancer pain due to bone metastasis"],"prefix":"10.1007","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4957-6030","authenticated-orcid":false,"given":"Daisuke","family":"Takei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keita","family":"Tagami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,23]]},"reference":[{"key":"1382_CR1","first-page":"4239","volume":"9","author":"XC Zhu","year":"2015","unstructured":"Zhu XC, Zhang JL, Ge CT, Yu YY, Wang P, Yuan TF, Fu CY (2015) Advances in cancer pain from bone metastasis. Drug Des Dev Ther 9:4239\u20134245","journal-title":"Drug Des Dev Ther"},{"key":"1382_CR2","doi-asserted-by":"publisher","first-page":"482","DOI":"10.21037\/atm.2020.03.55","volume":"8","author":"JF Huang","year":"2020","unstructured":"Huang JF, Shen J, Li X, Rengan R, Silvestris N, Wang M, Derosa L, Zheng X, Belli A, Zhang XL, Li YM, Wu A (2020) Incidence of patients with bone metastases at diagnosis of solid tumors in adults: a large population-based study. Ann Transl Med 8:482","journal-title":"Ann Transl Med"},{"key":"1382_CR3","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/s10549-011-1475-5","volume":"129","author":"M Yong","year":"2011","unstructured":"Yong M, Jensen A\u00d6, Jacobsen JB, N\u00f8rgaard M, Fryzek JP, S\u00f8rensen HT (2011) Survival in breast cancer patients with bone metastases and skeletal-related events: a population-based cohort study in Denmark (1999\u20132007). Breast Cancer Res Treat 129:495\u2013503","journal-title":"Breast Cancer Res Treat"},{"key":"1382_CR4","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.clbc.2016.07.001","volume":"16","author":"SR Harris","year":"2016","unstructured":"Harris SR (2016) Differentiating the causes of spontaneous rib fracture after breast cancer. Clin Breast Cancer 16:431\u2013436","journal-title":"Clin Breast Cancer"},{"key":"1382_CR5","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.h315","volume":"350","author":"CM Kane","year":"2015","unstructured":"Kane CM, Hoskin P, Bennett MI (2015) Cancer induced bone pain. BMJ 350:h315","journal-title":"BMJ"},{"key":"1382_CR6","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1007\/s11914-017-0354-3","volume":"15","author":"DP Milgrom","year":"2017","unstructured":"Milgrom DP, Lad NL, Koniaris LG, Zimmers TA (2017) bone pain and muscle weakness in cancer patients. Curr Osteoporos Rep 15:76\u201387","journal-title":"Curr Osteoporos Rep"},{"key":"1382_CR7","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.bone.2018.01.004","volume":"108","author":"L Chambard","year":"2018","unstructured":"Chambard L, Girard N, Ollier E, Rousseau JC, Duboeuf F, Carlier MC, Brevet M, Szulc P, Pialat JB, Wegrzyn J, Clezardin P, Confavreux CB (2018) Bone, muscle, and metabolic parameters predict survival in patients with synchronous bone metastases from lung cancers. Bone 108:202\u2013209","journal-title":"Bone"},{"key":"1382_CR8","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s00520-019-04843-9","volume":"28","author":"S Dohzono","year":"2020","unstructured":"Dohzono S, Sasaoka R, Takamatsu K, Hoshino M, Nakamura H (2020) Low paravertebral muscle mass in patients with bone metastases from lung cancer is associated with poor prognosis. Support Care Cancer 28:389\u2013394","journal-title":"Support Care Cancer"},{"key":"1382_CR9","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1053\/ctrv.2000.0210","volume":"27","author":"RE Coleman","year":"2001","unstructured":"Coleman RE (2001) Metastatic bone disease: clinical features, pathophysiology and treatment strategies. Cancer Treat Rev 27:165\u2013176","journal-title":"Cancer Treat Rev"},{"key":"1382_CR10","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1016\/j.biopha.2017.07.023","volume":"93","author":"I Zaporowska-Stachowiak","year":"2017","unstructured":"Zaporowska-Stachowiak I, \u0141uczak J, Hoffmann K, Stachowiak K, Bryl W, Sopata M (2017) Managing metastatic bone pain: new perspectives, different solutions. Biomed Pharmacother 93:1277\u20131284","journal-title":"Biomed Pharmacother"},{"key":"1382_CR11","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s13046-017-0578-1","volume":"36","author":"AS Gdowski","year":"2017","unstructured":"Gdowski AS, Ranjan A, Vishwanatha JK (2017) Current concepts in bone metastasis, contemporary therapeutic strategies and ongoing clinical trials. J Exp Clin Cancer Res 36:108","journal-title":"J Exp Clin Cancer Res"},{"key":"1382_CR12","doi-asserted-by":"publisher","first-page":"6047","DOI":"10.3390\/ijms20236047","volume":"20","author":"R Zaj\u0105czkowska","year":"2019","unstructured":"Zaj\u0105czkowska R, Kocot-K\u0119pska M, Leppert W, Wordliczek J (2019) Bone pain in cancer patients: mechanisms and current treatment. Int J Mol Sci 20:6047","journal-title":"Int J Mol Sci"},{"key":"1382_CR13","first-page":"321","volume":"11","author":"F Macedo","year":"2017","unstructured":"Macedo F, Ladeira K, Pinho F, Saraiva N, Bonito N, Pinto L, Goncalves F (2017) Bone metastases: an overview. Oncol Rev 11:321","journal-title":"Oncol Rev"},{"key":"1382_CR14","doi-asserted-by":"publisher","first-page":"202","DOI":"10.4329\/wjr.v7.i8.202","volume":"7","author":"GJ O\u2019Sullivan","year":"2015","unstructured":"O\u2019Sullivan GJ, Carty FL, Cronin CG (2015) Imaging of bone metastasis: an update. World J Radiol 7:202\u2013211","journal-title":"World J Radiol"},{"key":"1382_CR15","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1002\/(SICI)1097-0142(19971015)80:8+<1595::AID-CNCR10>3.0.CO;2-V","volume":"80","author":"DI Rosenthal","year":"1997","unstructured":"Rosenthal DI (1997) Radiologic diagnosis of bone metastases. Cancer 80:1595\u20131607","journal-title":"Cancer"},{"key":"1382_CR16","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1007\/s00330-006-0361-8","volume":"17","author":"GP Schmidt","year":"2007","unstructured":"Schmidt GP, Schoenberg SO, Schmid R, Stahl R, Tiling R, Becker CR, Reiser MF, Baur-Melnyk A (2007) Screening for bone metastases: whole-body MRI using a 32-channel system versus dual-modality PET-CT. Eur Radiol 17:939\u2013949","journal-title":"Eur Radiol"},{"key":"1382_CR17","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1093\/bja\/aen100","volume":"101","author":"A Delaney","year":"2008","unstructured":"Delaney A, Fleetwood-Walker SM, Colvin LA, Fallon M (2008) Translational medicine: cancer pain mechanisms and management. Br J Anaesth 101:87\u201394","journal-title":"Br J Anaesth"},{"key":"1382_CR18","first-page":"129","volume":"23","author":"CS Cleeland","year":"1994","unstructured":"Cleeland CS, Ryan KM (1994) Pain assessment: global use of the brief pain inventory. Ann Acad Med Singapore 23:129\u2013138","journal-title":"Ann Acad Med Singapore"},{"key":"1382_CR19","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.pain.2009.02.007","volume":"144","author":"RH Dworkin","year":"2009","unstructured":"Dworkin RH, Turk DC, Revicki DA, Harding G, Coyne KS, Peirce-Sandner S, Bhagwat D, Everton D, Burke LB, Cowan P, Farrar JT, Hertz S, Max MB, Rappaport BA, Melzack R (2009) Development and initial validation of an expanded and revised version of the Short-form McGill Pain Questionnaire (SF-MPQ-2). Pain 144:35\u201342","journal-title":"Pain"},{"key":"1382_CR20","first-page":"45","volume":"3","author":"AR Kachooei","year":"2015","unstructured":"Kachooei AR, Ebrahimzadeh MH, Erfani-Sayyar R, Salehi M, Salimi E, Razi S (2015) Short form-mcgill pain questionnaire-2 (SF-MPQ-2): a cross-cultural adaptation and validation study of the persian version in patients with knee osteoarthritis. Arch Bone Jt Surg 3:45\u201350","journal-title":"Arch Bone Jt Surg"},{"key":"1382_CR21","volume-title":"The brief pain inventory user guide","author":"CS Cleeland","year":"2009","unstructured":"Cleeland CS (2009) The brief pain inventory user guide. The University of Texas MD Anderson Cancer Center, Houston, TX"},{"key":"1382_CR22","doi-asserted-by":"publisher","first-page":"iv166","DOI":"10.1093\/annonc\/mdy152","volume":"29","author":"M Fallon","year":"2018","unstructured":"Fallon M, Giusti R, Aielli F, Hoskin P, Rolke R, Sharma M, Ripamonti CI, ESMO Guidelines Committee (2018) Management of cancer pain in adult patients: ESMO clinical practice guidelines. Ann Oncol 29:iv166\u2013iv191","journal-title":"Ann Oncol"},{"key":"1382_CR23","unstructured":"World Health Organization: WHO Guidelines for the Pharmacological and Radiotherapeutic Management of Cancer Pain in Adults and Adolescents 2018"},{"key":"1382_CR24","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1089\/jpm.2021.0438","volume":"25","author":"H Mawatari","year":"2022","unstructured":"Mawatari H, Shinjo T, Morita T, Kohara H, Yomiya K (2022) Revision of pharmacological treatment recommendations for cancer pain: clinical guidelines from the Japanese society of palliative medicine. J Palliat Med 25:1095\u20131114","journal-title":"J Palliat Med"},{"key":"1382_CR25","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1016\/S1470-2045(14)70183-4","volume":"15","author":"O Sartor","year":"2014","unstructured":"Sartor O, Coleman R, Nilsson S, Heinrich D, Helle SI et al (2014) Effect of radium-223 dichloride on symptomatic skeletal events in patients with castration-resistant prostate cancer and bone metastases: results from a phase 3, double-blind, randomised trial. Lancet Oncol 15:738\u2013746","journal-title":"Lancet Oncol"},{"key":"1382_CR26","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/s11912-019-0844-9","volume":"21","author":"DK Filippiadis","year":"2019","unstructured":"Filippiadis DK, Yevich S, Deschamps F, Jennings JW, Tutton S, Kelekis A (2019) The role of ablation in cancer pain relief. Curr Oncol Rep 21:105","journal-title":"Curr Oncol Rep"},{"key":"1382_CR27","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1200\/JCO.2004.03.097","volume":"22","author":"MP Goetz","year":"2004","unstructured":"Goetz MP, Callstrom MR, Charboneau JW, Farrell MA, Maus TP et al (2004) Percutaneous image-guided radiofrequency ablation of painful metastases involving bone: a multicenter study. J Clin Oncol 22:300\u2013306","journal-title":"J Clin Oncol"},{"key":"1382_CR28","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1007\/s10147-017-1133-y","volume":"22","author":"Z Liu","year":"2017","unstructured":"Liu Z, Xu Y, Liu ZL, Tian YZ, Shen XH (2017) Combined application of diclofenac and celecoxib with an opioid yields superior efficacy in metastatic bonecancerpain: a randomized controlled trial. Int J Clin Oncol 22:980\u2013985","journal-title":"Int J Clin Oncol"},{"key":"1382_CR29","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.1007\/s00520-018-4469-6","volume":"27","author":"AA Yousef","year":"2019","unstructured":"Yousef AA, Alzeftawy AE (2019) The efficacy of oral piroxicam fast-dissolving tablets versus sublingual fentanyl in incident breakthrough pain due to bone metastases: a double-blinded randomized study. Support Care Cancer 27:2171\u20132177","journal-title":"Support Care Cancer"},{"key":"1382_CR30","volume-title":"British National Formulary (BNF), No.75","author":"Joint Formulary Committee","year":"2018","unstructured":"Joint Formulary Committee (2018) British National Formulary (BNF), No.75. Pharmaceutical Press, London"},{"key":"1382_CR31","doi-asserted-by":"publisher","first-page":"204","DOI":"10.5055\/jom.2005.0044","volume":"1","author":"K Mystakidou","year":"2005","unstructured":"Mystakidou K, Katsouda E, Kouloulias V, Kouvaris J, Tsiatas M, Vlahos L (2005) Comparison of transdermal fentanyl with codeine\/paracetamol, in combination with radiotherapy, for the management of metastatic bone pain. J Opioid Manag 1:204\u2013210","journal-title":"J Opioid Manag"},{"key":"1382_CR32","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/j.1365-2710.2010.01239.x","volume":"37","author":"L Sima","year":"2012","unstructured":"Sima L, Fang WX, Wu XM, Li F (2012) Efficacy of oxycodone\/paracetamol for patients with bone-cancer pain: a multicenter, randomized, double-blinded, placebo-controlled trial. J Clin Pharm Ther 37:27\u201331","journal-title":"J Clin Pharm Ther"},{"key":"1382_CR33","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1177\/2050640618818305","volume":"7","author":"AD Farmer","year":"2019","unstructured":"Farmer AD, Drewes AM, Chiarioni G, De Giorgio R, O\u2019Brien T, Morlion B, Tack J (2019) Pathophysiology and management of opioid-induced constipation: European expert consensus statement. United European Gastroenterol J 7:7\u201320","journal-title":"United European Gastroenterol J"},{"key":"1382_CR34","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1111\/j.1365-2796.2006.01667.x","volume":"260","author":"P Vestergaard","year":"2006","unstructured":"Vestergaard P, Rejnmark L, Mosekilde L (2006) Fracture risk associated with the use of morphine and opiates. J Intern Med 260:76\u201387","journal-title":"J Intern Med"},{"key":"1382_CR35","first-page":"237","volume":"40","author":"J Thonsantia","year":"2014","unstructured":"Thonsantia J, Waikakul W, Wongvikrom W, Sihaban K (2014) Gabapentin as an adjuvant analgesic with opioids for the management of metastatic bone pain: randomized, double - blind, placebo - controlled crossover trial. Thai J Anesthesiol 40:237\u2013252","journal-title":"Thai J Anesthesiol"},{"key":"1382_CR36","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s40122-013-0009-8","volume":"2","author":"KF Sjolund","year":"2013","unstructured":"Sjolund KF, Yang R, Lee KH, Resnick M (2013) Randomized study of pregabalin in patients with cancer-induced bone pain. Pain Ther 2:37\u201348","journal-title":"Pain Ther"},{"key":"1382_CR37","first-page":"E547","volume":"16","author":"M Nishihara","year":"2013","unstructured":"Nishihara M, Arai YC, Yamamoto Y, Nishida K, Arakawa M, Ushida T, Ikeuchi M (2013) Combinations of low-dose antidepressants and low-dose pregabalin as useful adjuvants to opioids for intractable, painful bone metastases. Pain Physician 16:E547-552","journal-title":"Pain Physician"},{"key":"1382_CR38","first-page":"CD002068","volume":"2002","author":"R Wong","year":"2002","unstructured":"Wong R, Wiffen PJ (2002) Bisphosphonates for the relief of pain secondary to bone metastases. Cochrane Database Syst Rev 2002:CD002068","journal-title":"Cochrane Database Syst Rev"},{"key":"1382_CR39","doi-asserted-by":"publisher","first-page":"djv197","DOI":"10.1093\/jnci\/djv197","volume":"107","author":"P Hoskin","year":"2015","unstructured":"Hoskin P, Sundar S, Reczko K, Forsyth S, Mithal N, Sizer B, Bloomfield D, Upadhyay S, Wilson P, Kirkwood A, Stratford M, Jitlal M, Hackshaw A (2015) A multicenter randomized trial of Ibandronate compared with single-dose radiotherapy for localized metastatic bone pain in prostate cancer. J Natl Cancer Inst 107:djv197","journal-title":"J Natl Cancer Inst"},{"key":"1382_CR40","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/j.jpainsymman.2007.01.001","volume":"33","author":"J Gralow","year":"2007","unstructured":"Gralow J, Tripathy D (2007) Managing metastatic bone pain: the role of bisphosphonates. J Pain Symptom Manag 33:462\u2013472","journal-title":"J Pain Symptom Manag"},{"key":"1382_CR41","doi-asserted-by":"publisher","first-page":"2993","DOI":"10.1016\/j.ejca.2012.05.014","volume":"48","author":"HJ Meulenbeld","year":"2012","unstructured":"Meulenbeld HJ, van Werkhoven ED, Coenen JL, Creemers GJ, Loosveld OJ, de Jong PC, Ten Tije AJ, Foss\u00e5 SD, Polee M, Gerritsen W, Dalesio O, de Wit R (2012) Randomised phase II\/III study of docetaxel with or without risedronate in patients with metastatic Castration Resistant Prostate Cancer (CRPC), the Netherlands Prostate Study (NePro). Eur J Cancer 48:2993\u20133000","journal-title":"Eur J Cancer"},{"key":"1382_CR42","first-page":"293","volume":"4","author":"DR Clohisy","year":"2004","unstructured":"Clohisy DR, Mantyh PW (2004) Bone cancer pain and the role of RANKL\/OPG. J Musculoskelet Neuronal Interact 4:293\u2013300","journal-title":"J Musculoskelet Neuronal Interact"},{"key":"1382_CR43","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1097\/SPC.0b013e32830baac2","volume":"2","author":"A Lipton","year":"2008","unstructured":"Lipton A, Jun S (2008) RANKL inhibition in the treatment of bone metastases. Curr Opin Support Palliat Care 2:197\u2013203","journal-title":"Curr Opin Support Palliat Care"},{"key":"1382_CR44","doi-asserted-by":"publisher","first-page":"3497","DOI":"10.1007\/s00520-013-1932-2","volume":"21","author":"R von Moos","year":"2013","unstructured":"von Moos R, Body JJ, Egerdie B, Stopeck A, Brown JE, Damyanov D, Fallowfield LJ, Marx G, Cleeland CS, Patrick DL, Palazzo FG, Qian Y, Braun A, Chung K (2013) Pain and health-related quality of life in patients with advanced solid tumours and bone metastases: integrated results from three randomized, double-blind studies of denosumab and zoledronic acid. Support Care Cancer 21:3497\u20133507","journal-title":"Support Care Cancer"},{"key":"1382_CR45","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1200\/JCO.2010.32.5209","volume":"29","author":"CH Van Poznak","year":"2011","unstructured":"Van Poznak CH, Temin S, Yee GC, Janjan NA, Barlow WE, Biermann JS, Bosserman LD, Geoghegan C, Hillner BE, Theriault RL, Zuckerman DS, Von Roenn JH, American Society of Clinical Oncology (2011) American society of clinical oncology executive summary of the clinical practice guideline update on the role of bone-modifying agents in meta-static breast cancer. J Clin Oncol 29:1221\u20131227","journal-title":"J Clin Oncol"},{"key":"1382_CR46","doi-asserted-by":"publisher","first-page":"1814","DOI":"10.1097\/j.pain.0000000000001278","volume":"159","author":"H Zhang","year":"2018","unstructured":"Zhang H, Lund DM, Ciccone HA, Staatz WD, Ibrahim MM, Largent-Milnes TM, Seltzman HH, Spigelman I, Vanderah TW (2018) Peripherally restricted cannabinoid 1 receptor agonist as a novel analgesic in cancer-induced bone pain. Pain 159:1814\u20131823","journal-title":"Pain"},{"key":"1382_CR47","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1016\/j.jpain.2018.01.002","volume":"19","author":"KA Edwards","year":"2018","unstructured":"Edwards KA, Havelin JJ, Mcintosh MI, Ciccone HA, Pangilinan K, Imbert I, Largent-Milnes TM, King T, Vanderah TW, Streicher JM (2018) A kappa opioid receptor agonist blocks bone cancer pain without altering bone loss, tumor size, or cancer cell proliferation in a mouse model of cancer-induced bone pain. J Pain 19:612\u2013625","journal-title":"J Pain"},{"key":"1382_CR48","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1097\/j.pain.0000000000000965","volume":"158","author":"SA Grenald","year":"2017","unstructured":"Grenald SA, Doyle TM, Zhang H, Slosky LM, Chen Z, Largent-Milnes TM, Spiegel S, Vanderah TW, Salvemini D (2017) Targeting the S1P\/S1PR1 axis mitigates cancer-induced bone pain and neuroinflammation. Pain 158:1733\u20131742","journal-title":"Pain"}],"container-title":["Journal of Bone and Mineral Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00774-022-01382-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00774-022-01382-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00774-022-01382-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,29]],"date-time":"2023-05-29T01:05:26Z","timestamp":1685322326000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00774-022-01382-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,23]]},"references-count":48,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["1382"],"URL":"https:\/\/doi.org\/10.1007\/s00774-022-01382-y","relation":{},"ISSN":["0914-8779","1435-5604"],"issn-type":[{"value":"0914-8779","type":"print"},{"value":"1435-5604","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,23]]},"assertion":[{"value":"5 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All the authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}